Pioglitazone and Metformin Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa,. The primary component is Pioglitazone Hy.
Product ID | 0093-7677_2c5b651d-2dec-4357-b810-52e083079d5d |
NDC | 0093-7677 |
Product Type | Human Prescription Drug |
Proprietary Name | Pioglitazone and Metformin Hydrochloride |
Generic Name | Pioglitazone And Metformin Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-03-05 |
Marketing End Date | 2019-03-31 |
Marketing Category | ANDA / |
Application Number | ANDA091155 |
Labeler Name | Teva Pharmaceuticals USA, |
Substance Name | PIOGLITAZONE HY |
Active Ingredient Strength | 15 mg/1; mg/1 |
Pharm Classes | Peroxisome Prol |
NDC Exclude Flag | N |
Marketing Category | ANDA |
Application Number | ANDA091155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-03-05 |
Marketing End Date | 2019-03-31 |
Marketing Category | ANDA |
Application Number | ANDA091155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-04-24 |
Marketing End Date | 2019-03-31 |
NDC | Brand Name | Generic Name |
---|---|---|
0093-7677 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride |
0093-7678 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride |
42291-512 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride |
42291-513 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride |
64764-155 | Actoplus Met | pioglitazone and metformin hydrochloride |
64764-158 | Actoplus Met | pioglitazone and metformin hydrochloride |
64764-310 | Actoplus Met | pioglitazone and metformin hydrochloride |
64764-510 | Actoplus Met | pioglitazone and metformin hydrochloride |